← Back to Search

ABCp for Lower Back Pain

Phase 2
Recruiting
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 30 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether a new approach to managing low back pain will decrease healthcare resource utilization and improve quality of life.

Who is the study for?
This trial is for family physicians in Alberta treating patients with lower back pain. Physicians must be over 18, speak English, and understand written information to consent. Patients with low back pain due to recent accidents or other clinical trials are excluded.
What is being tested?
The study tests the Alberta Back Carepathway (ABCp) against usual care. ABCp trains physicians in guideline-based interventions for lower back pain at no extra cost, aiming to reduce healthcare resource use and improve quality of life.
What are the potential side effects?
Since this trial involves training in care pathways rather than medication or invasive procedures, traditional side effects are not a concern. However, there may be indirect effects related to changes in patient management.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 30 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 30 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Primary Care visits
Secondary study objectives
GP ordered LBP imaging
GP requested specialist consultations

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ABCpExperimental Treatment1 Intervention
The patient sees MD that follows ABCp, patient then enrolls in ABCp intervention based on MD's categorization of low back pain.
Group II: Usual CareActive Control1 Intervention
The patient receives "usual care" at the clinical site.

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
940 Previous Clinical Trials
433,803 Total Patients Enrolled
Canadian Chiropractic Research FoundationUNKNOWN
1 Previous Clinical Trials
25 Total Patients Enrolled
Bone and Joint Health SCNUNKNOWN

Media Library

Alberta Back Care Pathway (ABCp) Clinical Trial Eligibility Overview. Trial Name: NCT05452876 — Phase 2
Lower Back Pain Research Study Groups: ABCp, Usual Care
Lower Back Pain Clinical Trial 2023: Alberta Back Care Pathway (ABCp) Highlights & Side Effects. Trial Name: NCT05452876 — Phase 2
Alberta Back Care Pathway (ABCp) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05452876 — Phase 2
~0 spots leftby Dec 2024